Premaitha Health Plc (NIPT)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Premaitha Health Plc (NIPT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010974
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that assists in estimating the risk of trisomy. The IONA test helps obviate the expensive, unnecessary and invasive diagnostic procedures such as amniocentesis. The company provides NIPT tests and services to clinical laboratories and healthcare professionals. Premaitha Health offers its products directly to customers in Europe. It operates through a subsidiary, Yourgene Bioscience, in Taiwan, which provides it expanded market access in Asia. Premaitha Health is headquartered in Manchester, England, the UK.

Premaitha Health Plc (NIPT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Premaitha Health Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Premaitha Health Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Premaitha Health Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Premaitha Health Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Premaitha Health Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Premaitha Health Plc, Medical Equipment, Deal Details 11
Asset Purchase 11
Premaitha Health Acquires Assets Related to Molecular Diagnostics from Zoragen Biotech 11
Partnerships 12
GeNext Enters into Distribution Agreement with Premaitha Health 12
Premaitha Health Enters into Agreement with Servicios Geneticos OriGen 13
Esperite Enters into Agreement with Premaitha Health 14
Sagentia Enters into Agreement with Premaitha Health to Develop IONA Test for Prenatal Screening 15
Equity Offering 16
Premaitha Health to Raise USD1.9 Million in Private Placement of Shares 16
Premaitha Health Raises USD12.5 Million in Private Placement of Shares 17
Acquisition 18
Premaitha Health Acquires Yourgene Bioscience for USD9 Million 18
Vialogy Acquires Premaitha Health for USD17.6 Million in Reverse Takeover Transaction 19
Premaitha Health Plc – Key Competitors 20
Premaitha Health Plc – Key Employees 21
Premaitha Health Plc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Sep 29, 2017: Premaitha Health: Full year results to 31 March 2017 and half-year trading update 23
Jul 12, 2017: Premaitha Health: Investment Agreement Extension with Thermo Fisher Scientific 25
Dec 21, 2016: Premaitha Health: Half Year Results 26
Sep 30, 2016: Premaitha Health: Annual Results 2016 28
Sep 23, 2016: Premaitha Health Announces Investment agreement extension with Thermo Fisher Scientific 29
Corporate Communications 30
Jul 12, 2017: Premaitha Health: Investment Agreement Extension with Thermo Fisher Scientific 30
Sep 23, 2016: Premaitha Health Announces Investment agreement extension with Thermo Fisher Scientific 31
Sep 08, 2016: Premaitha Health Announces Directorate Change 32
Jul 06, 2016: Premaitha Health Announces Directorate Change 33
Legal and Regulatory 34
Jul 03, 2017: Premaitha Health Litigation Update 34
Jul 04, 2016: Premaitha Health: Progress on anti-trust objections to litigation 35
Jan 26, 2016: Premaitha Health: Update on UK Litigation Timing 36
Product News 37
01/15/2016: Premaitha Health welcomes recommendation for NHS provision of non-invasive prenatal testing 37
01/08/2016: Update on competitor patent litigation 38
01/05/2016: Premaitha Health launches Workflow Manager system for the IONA test to support clinical laboratory customers 39
Other Significant Developments 40
Jul 10, 2017: Premaitha announces two laboratory hub contracts in South East Asia 40
Jun 05, 2017: Premaitha Health: India Business Update 41
May 12, 2017: Premaitha Health: Update Re. Swiss Customer 42
Feb 07, 2017: Premaitha Health: Southern Europe Business Update 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Premaitha Health Plc, Medical Equipment, Key Facts, 2016 2
Premaitha Health Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Premaitha Health Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Premaitha Health Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Premaitha Health Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Premaitha Health Plc, Deals By Market, 2011 to YTD 2017 9
Premaitha Health Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Premaitha Health Acquires Assets Related to Molecular Diagnostics from Zoragen Biotech 11
GeNext Enters into Distribution Agreement with Premaitha Health 12
Premaitha Health Enters into Agreement with Servicios Geneticos OriGen 13
Esperite Enters into Agreement with Premaitha Health 14
Sagentia Enters into Agreement with Premaitha Health to Develop IONA Test for Prenatal Screening 15
Premaitha Health to Raise USD1.9 Million in Private Placement of Shares 16
Premaitha Health Raises USD12.5 Million in Private Placement of Shares 17
Premaitha Health Acquires Yourgene Bioscience for USD9 Million 18
Vialogy Acquires Premaitha Health for USD17.6 Million in Reverse Takeover Transaction 19
Premaitha Health Plc, Key Competitors 20
Premaitha Health Plc, Key Employees 21
Premaitha Health Plc, Subsidiaries 22

★海外企業調査レポート[Premaitha Health Plc (NIPT)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Havas SA:企業の戦略的SWOT分析
    Havas SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • SELEX Galileo Inc.:企業の戦略・SWOT・財務分析
    SELEX Galileo Inc. - Strategy, SWOT and Corporate Finance Report Summary SELEX Galileo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Briggs & Stratton Corp (BGG):企業の財務・戦略的SWOT分析
    Briggs & Stratton Corp (BGG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • CNH Industrial NV:企業の戦略・SWOT・財務情報
    CNH Industrial NV - Strategy, SWOT and Corporate Finance Report Summary CNH Industrial NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Genenta Science srl:製薬・医療:M&Aディール及び事業提携情報
    Summary Genenta Science srl (Geneta Science) is a biotechnology company that develops gene therapies based on transcriptional and mirRNA-mediated controls. The company develops gene transfer strategy into autologous hematopoietic stem and progenitor cells in order to target interferon-a expression t …
  • N.V. Nuon Energy:企業の戦略・SWOT・財務情報
    N.V. Nuon Energy - Strategy, SWOT and Corporate Finance Report Summary N.V. Nuon Energy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Knoll, Inc.:企業の戦略・SWOT・財務情報
    Knoll, Inc. - Strategy, SWOT and Corporate Finance Report Summary Knoll, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Comba Telecom Systems Holdings Limited (2342):企業の財務・戦略的SWOT分析
    Comba Telecom Systems Holdings Limited (2342) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Cardtronics UK Limited:企業の戦略・SWOT・財務情報
    Cardtronics UK Limited - Strategy, SWOT and Corporate Finance Report Summary Cardtronics UK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Accu-Break Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Accu-Break Pharmaceuticals Inc (Accu-Break) is a developer and provider of pharmaceutical tablet technologies for accurate and customized dosing. The company provides services such as patented technologies, product differentiation, life cycle management, APIs solutions, product enhancement, …
  • Phibro Animal Health Corp (PAHC):企業の財務・戦略的SWOT分析
    Phibro Animal Health Corp (PAHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Pierre & Vacances SA (VAC):企業の財務・戦略的SWOT分析
    Pierre & Vacances SA (VAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • NICO Life Insurance Co Ltd:企業の戦略的SWOT分析
    NICO Life Insurance Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Credit Agricole Group:企業のM&A・事業提携・投資動向
    Credit Agricole Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Credit Agricole Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Jack Chia Industries (Thailand) Public Company Ltd (JCT):企業の財務・戦略的SWOT分析
    Jack Chia Industries (Thailand) Public Company Ltd (JCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company …
  • Devon Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Devon Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Devon Energy Corp (Devon Energy) is an independent energy company. The company carries out exploration, development, and production of oil, natural gas and natural gas liquids (NGLs). It has its op …
  • Hybrigenics SA (ALHYG):企業の財務・戦略的SWOT分析
    Hybrigenics SA (ALHYG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Lantern Pharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Lantern Pharma Inc (Lantern Pharma) is a drug development company that discovers and develops therapies for various cancer types. The company’s pipeline products include Irofulven-1, an anti-tumor agent is developed to fight against multi-drug resistant cancers. Its Irofulven-1 is used for t …
  • Mott MacDonald Group Ltd:企業の戦略的SWOT分析
    Mott MacDonald Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • LookingGlass Cyber Solutions Inc:企業の戦略的SWOT分析
    LookingGlass Cyber Solutions Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆